LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 103 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.08 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,396 | -50.6% | 46,235 | +3.7% | 0.00% | -100.0% |
| Q2 2023 | $102,113 | +4.6% | 44,591 | +10.9% | 0.00% | 0.0% |
| Q1 2023 | $97,669 | +29.8% | 40,193 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $75,241 | -20.8% | 39,393 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $95,000 | +50.8% | 39,536 | +16.0% | 0.00% | – |
| Q2 2022 | $63,000 | -13.7% | 34,092 | -1.9% | 0.00% | – |
| Q1 2022 | $73,000 | -50.3% | 34,757 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $147,000 | -17.9% | 37,202 | +0.1% | 0.00% | 0.0% |
| Q3 2021 | $179,000 | +2.3% | 37,155 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $175,000 | +2.9% | 38,038 | +31.2% | 0.00% | 0.0% |
| Q1 2021 | $170,000 | +107.3% | 28,984 | +20.8% | 0.00% | – |
| Q4 2020 | $82,000 | +127.8% | 24,000 | -2.8% | 0.00% | – |
| Q3 2020 | $36,000 | -28.0% | 24,688 | -2.2% | 0.00% | – |
| Q2 2020 | $50,000 | +4.2% | 25,250 | +2.8% | 0.00% | – |
| Q1 2020 | $48,000 | -55.6% | 24,569 | -5.5% | 0.00% | – |
| Q4 2019 | $108,000 | +36.7% | 25,988 | -0.8% | 0.00% | – |
| Q3 2019 | $79,000 | -52.4% | 26,208 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $166,000 | +8.5% | 26,390 | -4.2% | 0.00% | 0.0% |
| Q1 2019 | $153,000 | -19.0% | 27,556 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $189,000 | -38.2% | 28,449 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $306,000 | -9.5% | 28,669 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $338,000 | +43.2% | 28,151 | +2.2% | 0.00% | 0.0% |
| Q1 2018 | $236,000 | -17.8% | 27,546 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $287,000 | -19.2% | 29,028 | +0.5% | 0.00% | 0.0% |
| Q3 2017 | $355,000 | -19.3% | 28,891 | +8.1% | 0.00% | -50.0% |
| Q2 2017 | $440,000 | +18.0% | 26,730 | +2.7% | 0.00% | +100.0% |
| Q1 2017 | $373,000 | +11.0% | 26,020 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $336,000 | -99.9% | 24,304 | -0.3% | 0.00% | -50.0% |
| Q3 2016 | $440,330,000 | +26.1% | 24,368 | +0.2% | 0.00% | +100.0% |
| Q2 2016 | $349,150,000 | +18.0% | 24,331 | -1.8% | 0.00% | 0.0% |
| Q1 2016 | $296,000,000 | -10.3% | 24,781 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $330,000,000 | +124428.3% | 24,781 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $265,000 | -99.9% | 24,658 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $198,263,000 | – | 24,629 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |